Metraipolis › archive › dc_8714fbc772e9

Apolipoprotein A5 reduces clearance of VLDL by altering apolipoprotein E content — Europe PMC PMID:41043689

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41043689
DOI
10.1016/j.jlr.2025.100917
License (as archived)
solo-consultazione
Archived
2026-11-09T16:14:20.642Z
SHA-256 of the archived text
1156e33fa64a20053e983565ea03779aa37ddca67d41d50b4eb3a6a32ba12d74
Stable URL of this page
https://metraipolis.com/documento/dc_8714fbc772e9

How to cite

Apolipoprotein A5 reduces clearance of VLDL by altering apolipoprotein E content — Europe PMC PMID:41043689 — Europe PMC (en), https://europepmc.org/article/MED/41043689 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8714fbc772e9 (Metraipolis archive dc_8714fbc772e9, sha256 1156e33fa64a20053e983565ea03779aa37ddca67d41d50b4eb3a6a32ba12d74)
BibTeX
@misc{dc8714fbc772e9,
  title = {Apolipoprotein A5 reduces clearance of VLDL by altering apolipoprotein E content — Europe PMC PMID:41043689},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41043689},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8714fbc772e9; sha256 1156e33fa64a20053e983565ea03779aa37ddca67d41d50b4eb3a6a32ba12d74},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41043689. Agents can read the archived copy with the MCP tool read_document.